Here’s a list of key deals reported across sectors this week:

Ocular Therapeutix (NASDAQ:OCUL) rose 6% amid takeover speculation. There’s speculation that a French pharmaceutical company is circling Ocular Therapeutix (NASDAQ:OCUL), according to traders, who cited a